MiR-221 expression affects invasion potential of human prostate carcinoma cell lines by regulating DVL2
- Author:
- No author available
- Journal Title:
- International Journal of Urology and Nephrology
- Issue:
- 5
- DOI:
- 10.3760/cma.j.issn.1673-4416.2012.05.005
- Key Word:
- 前列腺肿瘤;RNA;Prostate cancer Neoplasms;RNA
Abstract： Objectives To evaluate the effect of miR-221 on the neuroendocrine(NE) differentiation and invasive function of prostate cancer cells as a miRNA biomarker candidate for prostate cancer.Methods The expressions of 7 miRNAs in LNCaP,LNCaP-AI prostate cancer cell lines were detected by Northern blotting.LNCaP and LNCaP-AI cells cultured in androgen-depleted medium were transfected with different synthetic miRNAs.Their invasive abilities were evaluated by a matrigel invasion assay.Cell growth was assessed by using the CCK-8cell proliferation assay at different time points.The expression of neuron-specific enolase ( NSE ) and Dishevelled-2 (DVL2)during the neuroendocrine differentiation and migration respectively was measured by qRT-PCR and Western blot.Results The miR-221 level was significantly increased in androgen-independent prostate cancer (AIPC) cell line LNCaP-AI when compared with androgen -dependent prostate cancer (ADPC) cell line LNCaP.Overexpression of miR-221 in LNCaP cells significantly increased NSE expression and induced their NE differentiation.The suppression of miR-221 expression with anti-miR -221 increased the abilities of migration and invasion in LNCaP-AI cells.Meanwhile,the DVL2 mRNA and protein levels were upregulated after the transfection of anti -miR-221 in LNCaP-AI cells.Conclusions There is a significant difference in miR-221 expression between ADPC and AIPC cells.MiR-221 contributes to NE differentiation of ADPC cells,which may be the reason of androgen — independence.miR-221 may regulate the migration of AIPC cells through DVL2 as a key regulator in advanced prostate cancer.
- [1]Bonci D,De-Maria R,Biffoni M,etc.The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities.[J].2008,14(11).
- [2]Gandellini P,Pennati M,Supino R,etc.miR-205 Exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase Cepsilon.[J].2009,69(6).
- [3]Li T,Li D,Sha J.MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells.[J].2009,383(3).
- [4]Jose D, Debes,Donald J, Tindall.Mechanisms of androgen-refractory prostate cancer.[J].2004,351(15).
- [5]Xu J,Murray T,Siegel R,etc.Cancer statistics, 2007.[J].2007,57(1).
- [6]Rajewsky N,Chen K.The evolution of gene regulation by transcription factors and microRNAs.[J].2007,8(2).
- [7]Jiborn T,Abrahamsson PA,Bjartell A.Neuroendocrine differentiation in prostatic carcinoma during hormonal treatment.[J].1998,51(4).
- [8]Ciafre SA,Galardi S,Massalini S,etc.miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1.[J].2007,282(32).
- [9]M E, Cox,P D, Deeble,S, Lakhani,etc.Acquisition of neuroendocrine characteristics by prostate tumor cells is reversible: implications for prostate cancer progression.[J].1999,59.
- [10]Lee Y,Kim M,Han JJ,etc.MicroRNA genes are transcribed by RNA polymerase II[J].2004,23(20).
- [11]Sooryanarayana Varambally,et al,Ram-Shankar Mani,etc.Genomic Loss Of Microrna-101 Leads To Overexpression Of Histone Methyltransferase Ezh2 In Cancer[J].2008,322(5908).
- [12]Wallace TA,Croce CM,Yi M,etc.Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer.[J].2008,68(15).
- [13]Damber JE,Aus G.Prostate cancer.[J].2008,371(9625).
- [14]Zupo S,Croce CM,Rattan S,etc.Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia.[J].2002,99(24).
- [15]Sun T,Wang Q,Kantoff P,etc.The role of microRNA-221 and microRNA-222 in androgen-independent prostate cancer cell lines.[J].2009,69(8).
- [16]C L, Tso,W H, McBride,J, Sun,etc.Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells.[J].1900,6(4).